MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cardiovascular, Cardiac, Cardiology, Cardiometabolic Companies _ Imaging, Diagnostics, Health IT & Medical Devices
InfraReDx
Organization & Developments: InfraRedx
Parents
InfraReDx
Children
2011: LipiScan IVUS Now Approved in European Union (2011)
Called a Chemogram™
Can help cardiologists detect lipid core coronary plaques that are associated with heart attacks after stent implantation.
FDA clears InfraReDx's coronary imaging device InfraReDx has received FDA 510(k) clearance for its LipiScan IVUS Coronary Imagin
New diagnostic device for detection of vulnerable atherosclerotic plaques
The company said it plans to market the device by the end of the year and seek European approval to market it there next year(20
The LipiScan IVUS system employs proprietary optical imaging technology to overcome the challenges of heart motion, blood interference, and vascular access to perform NIR spectroscopic analysis of the vessel and produce a chemical map of lipid-core plaque
Jumps
*Key People: InfraRedx
Finance & Acquisitions: InfraRedDx